this, then there's money to be made here. And then also, of course, health care. Any of the sectors that should thrive and survive recession. So health care, consumer staples, anything like that. I really want to be focused on those companies that if we do hit a rough patch for the next year or so, that these companies will be able to continue to grow their revenues, grow their cash flow and pay that dividend. No, it makes a lot of sense. So one of the areas that I don't think you cover anymore at Oxford is biotech. And I remember, is it Adam Borstein? Yeah. I don't know if he's still at the street or not, but he's- Yeah, he's with Stat News. He became very big at the time, but a few years ago, I haven't really followed him too much. But I know you used to cover biotech. You used to go to the annual JP Morgan health care conference. You used to give me updates and everything. I know it's got to be a passion still. Are you looking at biotech? Because biotech, when you look at that (22/35)